Nuzenio

Md Ophthalmology Times

Md Ophthalmology Times entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Can AXPAXLI serve as a foundational therapy to improve durability in wet AMD? - Ophthalmology Times EuropeOphthalmology Times Europe · Sun, 09 Aug 2026 13:05:37 GMTCapsulotomy size may shift effective lens position, data suggest - Ophthalmology Times EuropeOphthalmology Times Europe · Fri, 07 Aug 2026 14:18:14 GMTFirst human trial of gene-silencing therapy launched to treat vision-threatening effects of Bardet-Biedl syndrome - Ophthalmology Times EuropeOphthalmology Times Europe · Fri, 07 Aug 2026 11:06:32 GMTCarl D. Regillo, MD, FASRS: Does sustained delivery outperform intermittent injections? - Ophthalmology Times EuropeOphthalmology Times Europe · Thu, 06 Aug 2026 16:07:14 GMTHow AI can help shape future clinical trials - Ophthalmology Times EuropeOphthalmology Times Europe · Wed, 05 Aug 2026 16:06:52 GMTBringing the Gulani classification to life: 4 pathways to the same destination - Ophthalmology Times EuropeOphthalmology Times Europe · Wed, 05 Aug 2026 11:06:48 GMTQUASAR 64-week results: aflibercept 8 mg in macular edema following RVO—Jordana G. Fein, MD, MS - Ophthalmology Times EuropeOphthalmology Times Europe · Tue, 04 Aug 2026 16:01:45 GMT

Timeline

Sun, 09 Aug 2026 13:05:37 GMTCan AXPAXLI serve as a foundational therapy to improve durability in wet AMD? - Ophthalmology Times Europe
Fri, 07 Aug 2026 14:18:14 GMTCapsulotomy size may shift effective lens position, data suggest - Ophthalmology Times Europe
Fri, 07 Aug 2026 11:06:32 GMTFirst human trial of gene-silencing therapy launched to treat vision-threatening effects of Bardet-Biedl syndrome - Ophthalmology Times Europe
Thu, 06 Aug 2026 16:07:14 GMTCarl D. Regillo, MD, FASRS: Does sustained delivery outperform intermittent injections? - Ophthalmology Times Europe
Wed, 05 Aug 2026 16:06:52 GMTHow AI can help shape future clinical trials - Ophthalmology Times Europe
Wed, 05 Aug 2026 11:06:48 GMTBringing the Gulani classification to life: 4 pathways to the same destination - Ophthalmology Times Europe

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Md Ophthalmology Times.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.